NOTES TO CONDENSED FINANCIAL STATEMENTS
UNAUDITED
NOTE 1
ORGANIZATION
AND BASIS OF PRESENTATION
Organization and Nature of Business
Code Green Apparel Corp. (the “
Company
”)
was incorporated in Nevada on December 11, 2007. On April 26, 2014, and with the appointment of George Powell as its CEO and Director,
the Company changed its business model to offer eco-friendly corporate apparel primarily constructed from recycled textiles.
The Company is a publicly held Nevada corporation,
whose common stock trades on the OTC Market Group, Inc.’s Pink Sheets under the trading symbol, “
CGAC.
”
Basis of Presentation
The accompanying unaudited interim condensed
financial statements of the Company have been prepared in accordance with U.S. generally accepted accounting principles (“
GAAP
”)
for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do
not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management,
all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating
results for the periods presented are not necessarily indicative of the results that may be expected for the year ending December
31, 2017. For further information, refer to the financial statements and footnotes thereto included in the Company’s annual
report on Form 10-K for the year ended December 31, 2016.
Going Concern
The Company has generated only limited
revenues from operations since inception. Since inception, it has incurred significant losses to date, and as of September 30,
2017, has a working capital deficit of approximately $3,000,000, and an accumulated deficit of approximately $15,700,000. The Company’s
ability to continue its operations is uncertain and is dependent upon its ability to implement a business plan sufficient to generate
a positive cash flow and/or raise capital to fund its operations.
These financial statements do not include
any adjustments to the amounts and classifications of assets and liabilities that might be necessary should the Company be unable
to continue operations in the normal course of business.
Use of Estimates
The preparation of financial statements
in conformity with accounting principles generally accepted in the United States of America requires management to make certain
estimates and assumptions that affect the reported amounts and timing of revenues and expenses, the reported amounts and classification
of assets and liabilities, and the disclosure of contingent assets and liabilities. These estimates and assumptions are based on
the Company’s historical results as well as management’s future expectations. The Company’s actual results could
vary materially from management’s estimates and assumptions. Additionally, interim results may not be indicative of the Company’s
results for future interim periods, or the Company’s annual results.
Cash and Cash Equivalents
Cash and cash equivalents include cash
on hand and cash in time deposits, certificates of deposit and all highly liquid debt instruments with original maturities of three
months or less. At September 30, 2017, and December 31, 2016, the Company did not have any cash equivalents.
Accounts Receivable
Accounts receivable are not collateralized
and interest is not accrued on past due accounts. Periodically, management reviews the adequacy of its provision for doubtful accounts
based on historical bad debt expense results and current economic conditions using factors based on the aging of its accounts receivable.
After management has exhausted all collection efforts, management writes off receivables and the related reserve. Additionally,
the Company may identify additional allowance requirements based on indications that a specific customer may be experiencing financial
difficulties. Actual bad debt results could differ materially from these estimates.
Inventories
Inventories are stated at the lower of
cost (first-in, first-out) or market. The Company periodically reviews its inventories for indications of slow movement and obsolescence
and records an allowance when it is deemed necessary. There was no inventory at September 30, 2017.
Revenue Recognition
The Company recognizes gross sales when
persuasive evidence of an arrangement exists, title transfer has occurred, the price is fixed or readily determinable, and collection
is reasonably assured. It recognizes revenue in accordance with Accounting Standards Codification (“
ASC
”) 605,
Revenue Recognition (“
ASC 605
”).
Stock Based Compensation
The Company from time to time issues shares
of common stock for services. These issuances have been valued based upon the quoted market price of the shares.
Disclosure About Fair Value of Financial
Instruments
The Company estimates that the fair value
of all financial instruments at September 30, 2017 and December 31, 2016, do not differ materially from the aggregate carrying
values of its financial instruments recorded in the accompanying condensed balance sheets. The estimated fair value amounts have
been determined by the Company using available market information and appropriate valuation methodologies. Considerable judgment
is required in interpreting market data to develop the estimates of fair value, and accordingly, the estimates are not necessarily
indicative of the amounts that the Company could realize in a current market exchange.
Derivative Financial Instruments
The Company evaluates its financial instruments
to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial
instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then
re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative
financial instruments, the Company uses the Black-Scholes-Merton pricing model to value the derivative instruments. The classification
of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the
end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based
on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.
The Company has determined
that certain outstanding convertible debt instruments include an
exercise price “
reset
” adjustment that qualifies as derivative financial instruments under the provisions
of ASC 815-40, Derivatives and Hedging - Contracts in an Entity’s Own Stock (“
ASC 815-40
”). Certain
of the convertible debentures have a variable exercise price, thus are convertible into an indeterminate number of shares for
which we cannot determine if we have sufficient authorized shares to settle the transaction with. Accordingly, the
embedded conversion option is a derivative liability and is marked to market through earnings at the end of each reporting
period. Any change in fair value during the period recorded in earnings as “
Other income (expense) - gain (loss) on
change in derivative liabilities.
”
|
|
Carrying
Value
|
|
|
Fair Value Measurements
Using Fair Value Hierarchy
|
|
|
|
|
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
Derivative liability – December 31, 2016
|
|
$
|
1,525,135
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,525,135
|
|
Derivative liability – September 30, 2017
|
|
$
|
1,899,414
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,899,414
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,525,135
|
|
Revaluation of derivative arising from
insufficient shares available for issuance
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(300,766
|
)
|
New embedded derivatives issued with indebtedness
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,048,072
|
|
Conversion
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(566,593
|
)
|
Change in derivative liability during the nine months ended September 30, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(806,434
|
)
|
Balance September 30, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,899,414
|
|
Net Income (Loss) Per Share
Basic earnings (loss) per share is computed
by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding for
the period. Diluted earnings (loss) per share reflects the potential dilution that could occur if securities or other contracts
to issue common stock were exercised or converted into common stock. Any anti-dilutive effects on net income (loss) per share are
excluded. The Company has 16,724,126,399 potentially dilutive securities outstanding as of September 30, 2017.
Income Taxes
The Company accounts for income taxes in
accordance with FASB ASC 740, “
Income Taxes,
” which requires that the Company recognize deferred tax liabilities
and assets based on the differences between the financial statement carrying amounts and the tax bases of assets and liabilities,
using enacted tax rates in effect in the years the differences are expected to reverse. Deferred income tax benefit (expense) results
from the change in net deferred tax assets or deferred tax liabilities. A valuation allowance is recorded when it is more likely
than not that some or all deferred tax assets will not be realized.
The Company has adopted the provisions
of FASB ASC 740-10-05
Accounting for Uncertainty in Income Taxes
. The ASC clarifies the accounting for uncertainty
in income taxes recognized in an enterprise’s financial statements. The ASC prescribes a recognition threshold and measurement
attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.
The ASC provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure
and transition. Open tax-years subject to IRS examination include 2013 - 2016.
Recent Accounting Pronouncements
In February 2016, the FASB issued ASU No.
2016-02, Leases (Topic 842) to increase transparency and comparability among organizations by recognizing lease assets and lease
liabilities on the balance sheet and disclosing key information about leasing arrangements. Topic 842 affects any entity that enters
into a lease, with some specified scope exemptions. The guidance in this ASU supersedes Topic 840, Leases. The core principle of
Topic 842 is that a lessee should recognize the assets and liabilities that arise from leases. A lessee should recognize in the
statement of financial position a liability to make lease payments (the lease liability) and a right-of-use asset representing
its right to use the underlying asset for the lease term. For public companies, the amendments in this ASU are effective for fiscal
years beginning after December 15, 2018, including interim periods within those fiscal years. The Company is currently evaluating
the impact of adopting ASU No. 2016-02 on its financial statements.
In March 2016, the FASB issued ASU 2016-08,
Revenue
from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net)
that
clarifies how to apply revenue recognition guidance related to whether an entity is a principal or an agent. ASU 2016-08 clarifies
that the analysis must focus on whether the entity has control of the goods or services before they are transferred to the customer
and provides additional guidance about how to apply the control principle when services are provided and when goods or services
are combined with other goods or services. The effective date for ASU 2016-08 is the same as the effective date of ASU 2014-09
as amended by ASU 2015-14, for annual reporting periods beginning after December 15, 2017, including interim periods within those
years. The Company has not yet determined the impact of ASU 2016-08 on its financial statements.
In April 2016, the FASB issued ASU 2016-10,
Revenue
from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing
, which provides further guidance
on identifying performance obligations and improves the operability and understandability of licensing implementation guidance.
The effective date for ASU 2016-10 is the same as the effective date of ASU 2014-09 as amended by ASU 2015-14, for annual reporting
periods beginning after December 15, 2017, including interim periods within those years. The Company has not yet determined the
impact of ASU 2016-10 on its financial statements.
NOTE 2 FIXED ASSETS, NET
Fixed assets consist of the following equipment:
|
|
September 30,
2017
|
|
|
December 31,
2016
|
|
|
|
|
|
|
|
|
Computer equipment
|
|
$
|
16,783
|
|
|
$
|
16,783
|
|
|
|
|
16,783
|
|
|
|
16,783
|
|
Less accumulated depreciation
|
|
|
(6,339
|
)
|
|
|
(3,821
|
)
|
Total
|
|
$
|
10,444
|
|
|
$
|
12,962
|
|
The aggregate depreciation charge to operations
was $2,518 and $2,307 for the nine months ended September 30, 2017 and 2016, respectively. The depreciation policies followed by
the Company are described in Note 1.
NOTE 3
NOTES
PAYABLE
During June 2016, the Company issued a
$200,000 promissory note in connection with the Asset Purchase Agreement, see Note 9. The note carries interest at 10% per annum
and is due June 23, 2018. Total outstanding debt was $200,000 at both September 30, 2017 and December 31, 2016. The accrued interest
on the note was $25,425 and $10,466 at September 30, 2017 and December 31, 2016, respectively.
During July 2016, the Company issued a
promissory note in the amount of $82,500. The note is currently in default. The note contains an original issue discount in the
amount of $7,500. The remaining balance due at September 30, 2017 and December 31, 2016 was $82,500 and $82,500, respectively.
The accrued interest on the note was $60,899 and $8,945 at September 30, 2017 and December 31, 2016, respectively.
During September 2016, the Company issued
a promissory note in the amount of $10,000. The note is due in six months. The note contains an original issue discount in the
amount of $650. The remaining balance due at September 30, 2017 and December 31, 2016 was $0 and $95, respectively. Interest accrues
at 12% and is paid daily. The accrued interest on the note was $0 and $0 at September 30, 2017 and December 31, 2016, respectively.
The balance of this note was paid in February 2017.
During January 2017, the Company issued
a promissory note in the amount of $20,000. The note was due February 15, 2017. The note requires an interest payment of $5,000
upon repayment. The remaining balance due at September 30, 2017 and December 31, 2016 was $0 and $0, respectively. The accrued
interest on the note was $0 and $0 at September 30, 2017 and December 31, 2016, respectively. The balance of this note and accrued
interest was paid in April 2017.
NOTE 4
CONVERTIBLE
NOTES
On May 1, 2014, the Company entered into
an agreement with Anubis Capital Partners, a business advisor. The agreement calls for monthly payments of $2,500 in service fees
along with the issuance of a $500,000 fully earned convertible debt that accrues interest at 8% per annum. The holder has the option
to convert any balance of principal and interest into common stock of the Company. The rate of conversion for the note is calculated
as the lowest of the 20 trading closing prices immediately preceding such conversion, discounted by 50%. During December 2015,
the Company issued 25,000,000 shares of common stock in payment of $212,500 of principal on this convertible debt. On June 29,
2017, Anubis Capital Partners sold $100,000 of the principal due under this note to an unrelated party. As a result, the Company
issued a replacement note with the same terms to the new holder. At September 30, 2017 and December 31, 2016, $20,000 was owed
in services fees, accrued interest was $11,337 and $88,795, and the outstanding convertible debt was $187,500 and $287,500, respectively.
During the year ended December 31, 2014,
the Company issued $173,500 of convertible notes. The convertible notes carry interest at 10% per annum and are due 24 months from
the date of issuance, June 2016 through September 2016. The note holders had the option to convert into shares of the Company’s
common stock after 180 days at 50% of the market price. During April and May of 2015, the Company issued 14,660,440 shares of common
stock upon conversion of $173,500 of principal amount outstanding under these convertible notes. At September 30, 2017 and December
31, 2016, the remaining accrued interest on the convertible notes was $12,027 and $12,027, respectively.
During December 2015, the
Company issued a one-year convertible note in the amount of $175,000. The convertible note is
currently in default, and contains a prepayment penalty of $25,000. The holder has the option to convert any balance of
principal into common stock of the Company. The rate of conversion for the note is calculated as the lowest of the 10 trading
closing prices immediately preceding such conversion, discounted by 32.5%. During December 2016, the Company issued
12,000,000 shares of common stock upon conversion of $13,770 of principal amount outstanding under this convertible note.
During May 2017, the original note holder sold the note to an unrelated party. As a result, the Company issued a replacement
note with the same terms to the new holder. During June 2017, the Company issued 70,119,900 shares of common stock upon
conversion of $48,436 of principal amount outstanding under this convertible note. During July 2017, the Company issued
35,450,000 shares of common stock upon conversion of $3,403 of principal amount outstanding under this convertible note.
During August 2017, the Company issued 76,200,000 shares of common stock upon conversion of $3,658 of principal amount
outstanding under this convertible note. During September 2017, the Company issued 133,517,700 shares of common stock upon
conversion of $6,409 of principal amount outstanding under this convertible note. The remaining balance due at September 30,
2017 and December 31, 2016 was $100,517 and $161,730, respectively. At September 30, 2017 and December 31, 2016, the
remaining accrued interest on the convertible note was $3,532 and $0, respectively.
During June 2016, the Company sold a convertible
note in the principal amount of $121,325. The convertible note was due in one year and contains an original issue discount in the
amount of $15,825. The holder has the option to convert any balance of principal into common stock of the Company after the initial
180 days. The rate of conversion for this note is calculated as the average of the three lowest closing prices of the Company’s
common stock during the 20 trading days immediately preceding such conversion, discounted by 50%. During April and June 2017, the
Company issued 62,498,139 shares of common stock upon conversion of $63,427 of principal amount outstanding under this convertible
note. The remaining balance due at September 30, 2017 and December 31, 2016 was $0 and $73,989, respectively. Interest accrues
at 12% per annum and is paid daily.
During September 2016, the Company sold
a one-year convertible note in the principal amount of $63,825. The convertible note is currently in default and contains an original
issue discount in the amount of $13,825. The holder has the option to convert any balance of principal into common stock of the
Company after the initial 180 days. The rate of conversion for this note is calculated as the average of the three lowest closing
prices of the Company’s common stock during the 20 trading days immediately preceding such conversion, discounted by 50%.
The remaining balance due at September 30, 2017 and December 31, 2016 was $13,030 and $53,481, respectively. Interest accrues
at 12% per annum and is paid daily.
During April 2017, the Company sold Carebourn
a Convertible Promissory Note in the principal amount of $135,575 (the “
April 2017 Carebourn Convertible Note
”),
pursuant to a Securities Purchase Agreement, dated April 17, 2017. The April 2017 Carebourn Convertible Note bears interest at
the rate of 12% per annum (22% upon an event of default) and is due and payable on April 17, 2018. The conversion price of the
April 2017 Carebourn Convertible Note is the average of the three lowest closing prices of the Company’s common stock during
the 20 trading days immediately preceding such conversion, discounted by 50%. The April 2017 Carebourn Convertible Note had an
original issue discount of $27,075. In addition, the Company paid $8,500 of Carebourn’s expenses and attorney fees in connection
with the sale of the note, which were included in the principal amount of the note. The remaining balance due at September 30,
2017 was $55,117. Interest accrues at 12% per annum and is paid daily.
During April 2017, pursuant to a Note Purchase
Agreement,
the Company sold a 10% Convertible Debenture in the principal amount of $32,500
(which included a $5,000 original issue discount) to Sojourn Investments, LP (“
Sojourn
” and the “
Sojourn
Debenture
”). The principal amount of the debenture accrues at 10% per annum until paid or converted into common stock
(18% upon the occurrence of an event of default).
The rate of conversion for the note is calculated as the lowest of the
20 trading closing prices immediately preceding such conversion, discounted by 42%.
The Sojourn
Debenture has a maturity date of January 12, 2018, provided the debenture can be repaid at any time, provided that if repaid more
than 30 days after the issuance date, the Company is required to pay 130% of the principal amount of the debenture, together with
accrued interest.
The remaining balance due at September 30, 2017 was $32,500. The accrued interest on the note was
$1,523 at September 30, 2017.
During May 2017, the Company sold
a one-year convertible note in the principal amount of $35,000. The convertible note contains an
original issue discount in the amount of $3,000. The holder has the option to convert any balance of principal into common
stock of the Company after the initial 180 days. The rate of conversion for this note is calculated as the average of the
three lowest closing prices of the Company’s common stock during the 20 trading days immediately preceding such
conversion, discounted by 35%. The note was repaid in full in June 2017. The remaining balance due at September 30, 2017 was
$0. Interest accrues at 12% per annum and is paid daily. The accrued interest on the note was $0 at September 30, 2017.
During May 2017, the Company sold
a one-year convertible note in the principal amount of $100,000. The convertible note contains an
original issue discount in the amount of $9,500. The holder has the option to convert any balance of principal into common
stock of the Company after the initial 180 days. The rate of conversion for this note is calculated as the average of the
three lowest closing prices of the Company’s common stock during the 20 trading days immediately preceding such
conversion, discounted by 45%. The remaining balance due at September 30, 2017 was $100,000. Interest accrues at 10% per
annum. The accrued interest on the note was $3,507 at September 30, 2017.
During June 2017, the Company sold
a one-year convertible note in the principal amount of $100,000. The convertible note contains an
original issue discount in the amount of $11,083. The holder funded an additional $50,000 in August 2017, with an original
discount of $4,167. The total purchase price of the note is $150,000 with an original discount of $15,250. The holder has the
option to convert any balance of principal into common stock of the Company after 180 days from the date of funding. The rate
of conversion for this note is calculated as the average of the three lowest closing prices of the Company’s common
stock during the 20 trading days immediately preceding such conversion, discounted by 42%. The remaining balance due at
September 30, 2017 was $150,000. Interest accrues at 10% per annum. The accrued interest on the note was $2,458 at September
30, 2017.
On June 29, 2017, the Company
issued a replacement note in the amount of $100,000, related to the Anubis Capital Partners note dated May 1, 2014. The
replacement note accrues interest at 8% per annum. The holder has the option to convert any balance of principal and interest
into common stock of the Company. The rate of conversion for the note is calculated as the lowest of the 20 trading closing
prices immediately preceding such conversion, discounted by 58%. During July 2017, the Company issued 33,781,609 shares of
common stock in payment of $5,878 of principal on this convertible debt. During September 2017, the Company issued 86,171,725
shares of common stock in payment of $4,998 of principal on this convertible debt. At September 30, 2017 and December 31,
2016, accrued interest was $1,916 and $0, and the outstanding convertible debt was $89,124 and $0, respectively.
On June 29, 2017, the Company sold
three one-year convertible notes in the principal amount of $210,000. The convertible notes contain an original issue
discount in the amount of $20,000. The funds were received July 3, 2017. The holder has the option to convert any balance of
principal into common stock of the Company after the initial 180 days. The rate of conversion for this note is calculated as
the average of the three lowest closing prices of the Company’s common stock during the 20 trading days immediately
preceding such conversion, discounted by 42%. The remaining balance due at September 30, 2017 was $210,000. Interest accrues
at 8% per annum. The accrued interest on the note was $4,281 at September 30, 2017.
Derivative Liability
On May 1, 2014, the Company secured $500,000
in the form of a convertible promissory note. The note bears interest at the rate of 8% per annum until it matures, or until there
is an event of default. The note matured on May 1, 2015. The holder has the option to convert any balance of principal and interest
into common stock of the Company. The rate of conversion for the note is calculated as the lowest of the 20 trading closing prices
immediately preceding such conversion, discounted by 50%.
On December 3, 2015, the Company secured
$175,000 in the form of a convertible promissory note. The note does not bear interest until or unless there is an event of default.
The note matured on December 3, 2016. The holder has the option to convert any balance of principal into common stock of the Company.
The rate of conversion for the note is calculated as the lowest of the 10 trading closing prices immediately preceding such conversion,
discounted by 32.5%.
On June 15, 2016, the Company secured $121,325
in the form of a convertible promissory note. The note bears interest at 12% per annum. The note matured on June 15, 2017. The
holder has the option to convert any balance of principal into common stock of the Company after the initial 180 days. The rate
of conversion for this note is calculated as the average of the three lowest closing prices of the Company’s common stock
during the 20 trading days immediately preceding such conversion, discounted by 50%.
On September 23, 2016, the Company secured
$63,825 in the form of a convertible promissory note. The note bears interest at 12% per annum. The note matured on September 23,
2017. The holder has the option to convert any balance of principal into common stock of the Company after the initial 180 days.
The rate of conversion for this note is calculated as the average of the three lowest closing prices of the Company’s common
stock during the 20 trading days immediately preceding such conversion, discounted by 50%.
During April 2017, the Company sold Carebourn
a Convertible Promissory Note in the principal amount of $135,575 (the “
April 2017 Carebourn Convertible Note
”),
pursuant to a Securities Purchase Agreement, dated April 17, 2017. The April 2017 Carebourn Convertible Note bears interest at
the rate of 12% per annum (22% upon an event of default) and is due and payable on April 17, 2018. The conversion price of the
April 2017 Carebourn Convertible Note is the average of the three lowest closing prices of the Company’s common stock during
the 20 trading days immediately preceding such conversion, discounted by 50%. The April 2017 Carebourn Convertible Note had an
original issue discount of $27,075. In addition, the Company paid $8,500 of Carebourn’s expenses and attorney fees in connection
with the sale of the note, which were included in the principal amount of the note. Interest accrues at 12% per annum and is paid
daily.
During April 2017, pursuant to a Note Purchase
Agreement,
the Company sold a 10% Convertible Debenture in the principal amount of $32,500
(which included a $5,000 original issue discount) to Sojourn (the “
Sojourn Debenture
”). The principal amount
of the debenture accrues at 10% per annum until paid or converted into common stock (18% upon the occurrence of an event of default).
The rate of conversion for the note is calculated as the lowest of the 20 trading closing prices immediately preceding such
conversion, discounted by 42%.
The Sojourn Debenture has a maturity date of January 12, 2018,
provided the debenture can be repaid at any time, provided that if repaid more than 30 days after the issuance date, the Company
is required to pay 130% of the principal amount of the debenture, together with accrued interest.
During May 2017, the Company sold a convertible
note in the principal amount of $100,000. The convertible note is due in one year and contains an original issue discount in the
amount of $9,500. The holder has the option to convert any balance of principal into common stock of the Company after the initial
180 days. The rate of conversion for this note is calculated as the average of the three lowest closing prices of the Company’s
common stock during the 20 trading days immediately preceding such conversion, discounted by 45%. Interest accrues at 10% per annum.
During June 2017, the Company sold a convertible
note in the principal amount of $100,000. The convertible note is due in one year and contains an original issue discount in the
amount of $11,083. The holder funded an additional $50,000 in August with an original discount of $4,167. The total purchase price
of the note is $150,000 with an original discount of $15,250. The holder has the option to convert any balance of principal into
common stock of the Company after the initial 180 days. The rate of conversion for this note is calculated as the average of the
three lowest closing prices of the Company’s common stock during the 20 trading days immediately preceding such conversion,
discounted by 42%. Interest accrues at 10% per annum.
On June 29, 2017, the Company issued a
replacement note in the amount of $100,000, related to the Anubis Capital Partners note dated May 1, 2014. The note accrues interest
at 8% per annum. The holder has the option to convert any balance of principal and interest into common stock of the Company. The
rate of conversion for the note is calculated as the lowest of the 20 trading closing prices immediately preceding such conversion,
discounted by 50%.
On June 29, 2017, the Company sold three
convertible notes in the principal amount of $210,000. The convertible notes are due in one year and contain an original issue
discount in the amount of $20,000. The funds were received July 3, 2017. The holder has the option to convert any balance of principal
into common stock of the Company after the initial 180 days. The rate of conversion for this note is calculated as the average
of the three lowest closing prices of the Company’s common stock during the 20 trading days immediately preceding such conversion,
discounted by 42%. The remaining balance due at September 30, 2017 was $210,000. Interest accrues at 8% per annum.
Due to the variable conversion price associated
with these convertible promissory notes, the Company has determined that the conversion feature is considered a derivative liability.
The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives
as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date.
The initial fair values of the embedded debt
derivatives of $500,842, $227,746, $322,660, $108,458, $782,714, $87,897, $67,152, $466,458, $300,415, and $343,436, respectively,
were allocated between debt discount and interest expense according to the face value of the debt. During the nine months
ended September 30, 2017 and 2016, $1,384,997 and $431,118, respectively, was charged to current period operations as interest
expenses. The fair value of the described embedded derivative was determined using the Black-Scholes Model with the following
assumptions:
(1) risk free interest rate of
|
0.10% to 0.45%
|
(2) dividend yield of
|
0%;
|
(3) volatility factor of
|
248% to 441%;
|
(4) an expected life of the conversion feature of
|
365 days; and
|
(5) estimated fair value of the Company’s common stock of
|
$0.0001 to $0.008 per share.
|
During the nine months ended September
30, 2017, the Company recorded a gain on fair value of derivative of $806,434.
The following table represents the Company’s
derivative liability activity for the nine months ended September 30, 2017:
Balance at December 31, 2016
|
|
$
|
1,525,135
|
|
Revaluation due to insufficient shares available for issuance
|
|
|
(300,766
|
)
|
Valuation upon issuance of debts
|
|
|
2,048,072
|
|
Conversion
|
|
|
(566,593
|
)
|
Change in derivative liability during the nine months ended September 30, 2017
|
|
|
(806,434
|
)
|
Balance September 30, 2017
|
|
$
|
1,899,414
|
|
NOTE 5
DERIVATIVE
FINANCIAL INSTRUMENTS
The following table presents the components
of the Company’s derivative financial instruments associated with convertible promissory notes (See Note 4) which have no
observable market data and are derived using the Black-Scholes option pricing model measured at fair value on a recurring basis,
using Level 1 and 3 inputs to the fair value hierarchy, at September 30, 2017 and December 31, 2016:
|
|
September 30,
2017
|
|
|
December 31,
2016
|
|
Embedded conversion features
|
|
$
|
1,638,733
|
|
|
$
|
963,688
|
|
Insufficient shares
|
|
|
260,681
|
|
|
|
561,447
|
|
Derivative liability
|
|
$
|
1,899,414
|
|
|
$
|
1,525,135
|
|
These derivative financial instruments arise as a result of applying
ASC 815 Derivative and Hedging
(“
ASC
815
”), which requires the Company to make a determination whether an equity-linked financial instrument, or embedded
feature, is indexed to the entity’s own stock. This guidance applies to any freestanding financial instrument or embedded
features that have the characteristics of a derivative, and to any freestanding financial instruments that are potentially settled
in an entity’s own stock.
During the nine months ended September
30, 2017, the Company had outstanding notes with embedded conversion features and the Company did not, at this date, have a sufficient
number of authorized and available shares of common stock to settle the outstanding contracts which triggered the requirement to
account for these instruments as derivative financial instruments until such time as the Company has sufficient authorized shares.
NOTE 6 LEASE COMMITMENTS
Laguna Beach Office
The Company is obligated under a commercial
real estate lease agreement. The lease is for a term of 60 months which began February 1, 2016 and expires January 31, 2021. The
lease calls for current monthly rental payments of $3,438.
Dallas Office
The Company was obligated under a commercial
real estate sublease agreement. The sublease was for a term of seven months which began on August 1, 2016 and expired on February
28, 2017. The lease called for current monthly rental payments of $2,200.
Rental expense for the nine months ended
September 30, 2017 and 2016 was $28,538 and $35,337, respectively. Future minimum rental payments for the remaining terms are as
follows:
Year Ending December 31,
|
|
|
Amount
|
|
2018 – remaining three months
|
|
|
$
|
10,314
|
|
2019
|
|
|
|
41,256
|
|
2020
|
|
|
|
41,256
|
|
2021
|
|
|
|
3,438
|
|
Total
|
|
|
$
|
96,264
|
|
NOTE 7 STOCKHOLDERS’ EQUITY
Effective on August 3, 2017, George J.
Powell, III, our Chief Executive Officer, Interim Chief Financial Officer, Secretary and Director, and the holder of all 1,000
shares of our outstanding Series A Preferred Stock, which provide the holder thereof the power to vote on all stockholder matters
(including, but not limited to at every meeting of the stockholders of the Company and upon any action taken by stockholders of
the Company with or without a meeting) equal to fifty-one percent (51%) of the total vote, executed a written consent in lieu of
the 2017 annual meeting of stockholders (the “
Majority Stockholder Consent
”), approving the following matters:
|
●
|
the appointment of two members to the Company’s Board of Directors (Mr. Powell and Thomas H. Witthuhn);
|
|
●
|
the adoption of the Code Green Apparel Corp. 2017 Equity Incentive Plan;
|
|
●
|
The filing of a Certificate of Amendment to the Company’s Articles of Incorporation to increase the number of authorized shares of the Company’s capital stock to five billion (5,000,000,000) shares, consisting of four billion nine hundred ninety million (4,990,000,000) shares of common stock, $0.001 par value per share and ten million (10,000,000) shares of preferred stock, $0.001 par value per share, without affecting or modifying the Company’s previously designated shares of preferred stock in any way (the “Amendment”);
|
|
●
|
authority for our Board of Directors, without further stockholder approval, to effect a reverse stock split of all of the outstanding common stock of the Company, by the filing of a Certificate of Amendment to the Company’s Articles of Incorporation with the Secretary of State of Nevada, in a ratio of between one-for-one hundred and one-for-one thousand, with the Company’s Board of Directors having the discretion as to whether or not the reverse split is to be effected, and with the exact exchange ratio of any reverse split to be set at a whole number within the above range as determined by the Board of Directors in its sole discretion, at any time before the earlier of (a) August 3, 2018; and (b) the date of the Company’s 2018 annual meeting of stockholders;
|
|
●
|
the appointment of Soles, Heyn & Company LLP as the Company’s independent registered public accounting firm;
|
|
●
|
an advisory vote on the frequency of an advisory vote on executive compensation; and
|
|
●
|
an advisory vote on executive compensation.
|
In accordance with Rule 14c-2 of the Exchange
Act, the corporate actions became effective forty (40) days after the date notice of the internet availability of an Information
Statement disclosing the Majority Stockholder Consent was first sent to stockholders, which date was September 25, 2017.
On December 21, 2017, the Amendment was
filed with, and became effective with the Secretary of State of Nevada. The increase in authorized shares is reflected in the balance
sheets.
On April 12, 2017, our Board of Directors
and majority shareholder (i.e., George J. Powell, III, the Company’s Chief Executive Officer and Director, who holds (i)
1,000 shares of Series A Preferred Stock, which provides the holder thereof the right to vote 51% of the vote on all shareholder
matters and (ii) 89,115,016 shares of the Company’s outstanding common stock), via a written consent to action without meeting,
approved the filing of a Certificate of Amendment to our Articles of Incorporation to increase the authorized common stock of the
Company, from one billion (1,000,000,000) shares of common stock, $0.001 par value per share, to one billion, nine hundred and
ninety million (1,990,000,000) shares of common stock, $0.001 par value share. The increase in authorized shares is reflected in
the balance sheets.
On April 13, 2017, the Company filed the
April 2017 amendment with the Nevada Secretary of State, which became effective on the same date.
On January 9,
2017, the Company issued 10,000,000 shares of its restricted common stock to its then newly appointed Director and COO, as a signing
bonus for his appointment to the Company’s Board of Directors. The shares had a fair market value of $30,000.
On February 9, 2017, the Company entered
into an Advertising Services Agreement (the “
Advertising Agreement
”) with Cicero Consulting Group, LLC (“
Cicero
”),
pursuant to which Cicero agreed to provide marketing and advertising services to the Company for a term of six months. In consideration
for agreeing to provide those services the Company agreed to issue Cicero 32 million shares of common stock. The value of the 32,000,000
shares is $96,000. Due to the terms of the agreement, $96,000 has been recorded in the statement of operations for the nine months
ended September 30, 2017.
During the nine
months ended September 30, 2017, the Company issued 59,220,554 shares of common stock in settlement of $736,184 of principal and
interest indebtedness and recorded a net gain on conversion of $59,616.
Series A Preferred Stock
On May 22, 2015, the Company designated
a series of Series A Preferred Stock. The holders of the Series A Preferred Stock are not entitled to receive dividends paid on
the Company’s common stock. The holders of the Series A Preferred Stock are not entitled to any liquidation preferences.
The shares of the Series A Preferred Stock have no conversion rights. The Series A Preferred Stock provide the holder thereof the
power to vote on all shareholder matters (including, but not limited to at every meeting of the stockholders of the Company and
upon any action taken by stockholders of the Company with or without a meeting) equal to fifty-one percent (51%) of the total vote.
Following the third anniversary of the original issuance of the Series A Preferred Stock, the Company has the option with (a) the
unanimous consent or approval of all members of the Board of Directors of the Company; (b) the approval of the holders of a majority
of the outstanding shares of Series A Preferred Stock; and (c) the approval of any interest or option holder(s) of such Series
A Preferred Stock, to redeem any and all outstanding shares of the Series A Preferred Stock by paying the holders a redemption
price of $100 per share.
Series B Preferred Stock
On December 7, 2015, the Company designated
a series of Series B Preferred Stock. The Series B Preferred Stock have an original issue price and liquidation preference (pro
rata with the common stock) of $10.00 per share. The Series B Preferred Stock provides the holders thereof the right to convert
such shares of Series B Preferred Stock into common stock on a 100-for-one basis, provided that no conversion can result in the
conversion of more than that number of shares of Series B Preferred Stock, if any, such that, upon such conversion, the aggregate
beneficial ownership of the Company’s common stock of any such holder and all persons affiliated with any such holder as
described in Rule 13d-3 is more than 4.99% of the Company’s common stock then outstanding (the “
Maximum Percentage
”).
For so long as any shares of the Series B Convertible Preferred Stock remain issued and outstanding, the holders thereof are entitled
to vote that number of votes as equals the number of shares of common stock into which such holder’s aggregate shares of
Series B Convertible Preferred Stock are convertible, subject to the Maximum Percentage.
On December 7, 2015, the Company entered
into an Exchange Agreement (the “
Exchange
”) with its shareholder, Dr. Eric H. Scheffey, whereby Dr. Scheffey
exchanged forty million (40,000,000) shares of the Company’s restricted common stock for 40,000 shares of the Company’s
Series B Preferred Stock.
On January 4,
2016, the Company sold 25,000 shares of its restricted Series B Preferred Stock in connection with a Subscription Agreement dated
December 7, 2015 (the January 1, 2016 payment) and received $250,000. The intrinsic value, the difference between the subscription
price and the underlying price of the common stock on the date of the subscription agreement, has been valued at $250,000. Accordingly,
this Discount attributable to beneficial conversion privilege of preferred stock has been recorded as a dividend in the current
period and an increase in additional paid-in capital.
NOTE 8 GOING
CONCERN
The accompanying consolidated financial
statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of
assets and the liquidation of liabilities in the normal course of business. The Company has had only limited revenues since inception.
Since inception, it has incurred significant losses to date, and as of September 30, 2017, has an accumulated deficit of $15,734,857
and has a working capital deficit of $2,925,369. These factors raise substantial doubt about the Company’s ability to continue
as a going concern. The Company’s ability to continue its operations is uncertain and is dependent upon its ability to implement
a business plan sufficient to generate positive cash flow and/or raise capital to fund its operations. These financial statements
do not include any adjustments to the amounts and classifications of assets and liabilities that might be necessary should the
Company be unable to continue operations in the normal course of business.
NOTE 9
SUBSEQUENT
EVENTS
During December 2017, we sold
a Convertible Promissory Note to More Capital, LLC (“
More Capital
”). The note had a purchase price of $25,000,
a face amount of $32,200, an original issue discount of $4,200, a due date of June 13, 2018 and an interest rate of 10% per annum.
We also agreed to pay $3,000 of More Capital’s expenses associated with the transaction. At any time 90 days after the issuance
date the principal amount of the note can be converted into our common stock at the option of the holder, subject to a 4.99% beneficial
ownership limitation, at a conversion price equal to 50% of the average of the three lowest quoted sales prices for our common
stock on the 20 trading days prior to conversion, subject to an additional discount of 10% in the event our common stock is subject
to a DTC chill. We can prepay the note subject to certain prepayment penalties. We also provided More Capital a right of first
refusal to provide additional funding during the period the note is outstanding. The note is payable by way of daily withdrawals
from our bank account in the amount of $134. We also agreed that if we provide any financing source more favorable term(s) than
More Capital while the note is outstanding that the More Capital note would, at the option of More Capital, be amended to include
such more favorable term(s). The note contains various penalties and liquidated damages upon the occurrence of an event of default.
During December 2017, we entered into
a Securities Purchase Agreement and sold a 12% Convertible Redeemable Note in the amount of $58,200 to Adar Bays, LLC
(“
Adar Bays
” and the “
Adar Bays Note
”). The amount owed under the Adar Bays Note is
convertible into shares of our common stock at a conversion price equal to 58% of the lowest trading price of our common
stock for the 20 trading days prior to conversion, accrues interest at 12% per annum until paid in full, included an original
issue discount (OID) of $5,700 and has a due date of December 20, 2018. In the event restrictions are placed on our stock by
the Depository Trust Company, the conversion rate would be adjusted to 48% of the lowest trading price of our common stock
for the 20 trading days prior to conversion. The note also contains a prohibition on conversion if such conversion would
result in Adar Bays holding more than 9.9% of our outstanding stock. The note also contains various penalties and
liquidated damages upon the occurrence of an event of default.
We also entered into a second 12% Convertible
Redeemable Note with Adar Bay with substantially similar terms as the Adar Bays Note (the “
2
nd
Adar Bays Note
”),
provided that instead of funding the 2
nd
Adar Bay Note in cash, in connection with our entry into the 2
nd
Adar Bay Note, Adar Bay provided us a Collateralized Secured Promissory Note in the amount of $52,500 which represented amounts
owed under the note and which note is due December 20, 2018. The note accrues interest at the rate of 12% per annum until paid
in full. Amounts due under the Collateralized Secured Promissory Note are offset against amounts due under the 2
nd
Adar
Bays Note until paid in full. We can prepay the note subject to certain prepayment penalties. The note contains various penalties
and liquidated damages upon the occurrence of an event of default.
During December 2017, we entered
into a Securities Purchase Agreement with Carebourn Capital, L.P. (“Carebourn”) and sold Carebourn a 12% Convertible
Note in the principal amount of $66,700 (the “
Carebourn December 2017 Note
”). As part of the purchase agreement,
we provided Carebourn a right of first refusal to participate in future offerings for 12 months, subject to certain exceptions.
We also paid $8,000 of Carebourn’s expenses associated with the offering. The Carebourn December 2017 Note is convertible
into shares of our common stock at any time 90 days after the sale date at a conversion price equal to 58% of the lowest trading
price of our common stock for the last 20 trading days prior to conversion (subject to reductions of up to an additional
15% in the conversion price percentage upon the occurrence of certain defaults under the note), accrues interest at 12% per annum,
had an OID of $8,700 and a due date of December 18, 2018. We can prepay the note subject to certain prepayment penalties. The note
contains various penalties and liquidated damages upon the occurrence of an event of default. The note is payable by way of daily
withdrawals from our bank account in the amount of $278, which begin March 1, 2018. We also agreed that if we provide any financing
source more favorable term(s) than the note while the note is outstanding that note would, at the option of Carebourn, be amended
to include such more favorable term(s). We also provided Carebourn a right of first refusal to provide additional funding during
the period the note is outstanding.
On December 21, 2017, we filed an Amendment
with the Secretary of State of Nevada to increase our authorized number of shares of common stock to 5,000,000,000.
Effective on
January 2, 2018, Thomas H. Witthuhn, a member of the Company’s Board of Directors and the Chief Operating Officer of the
Company resigned as the Chief Operating Officer of the Company.